![mesh enabler inventor students mesh enabler inventor students](http://fabacademy.org/archives/2015/as/students/lee.sungeun/class02_25.png)
![mesh enabler inventor students mesh enabler inventor students](https://i.ytimg.com/vi/IT88rrF98fw/maxresdefault.jpg)
The company said it was developing proprietary technology that required gathering a smaller amount of blood than a conventional intravenous draw and was more portable than traditional tests sent off to a lab. In 2003, Holmes dropped out of Stanford University at 19 to found Theranos with the goal of disrupting the blood-testing industry. "We worked for years with teams of scientists and engineers to miniaturize all the technologies in the laboratory," Holmes testified, according to The Wall Street Journal. Holmes pulled down her COVID mask, appeared composed on the stand and at times smiled while answering questions about herself and Theranos. Next it was Holmes' turn, though her attorneys hadn't made prior indications she'd testify. The lawyers said Bonanni's testimony will show Holmes made genuine attempts to fix problems at Theranos and that the prosecution failed to mention progress made by the company. Then the defense called Theranos board member Fabrizio Bonanni to the stand.
![mesh enabler inventor students mesh enabler inventor students](https://i0.wp.com/pinter.org/wp-content/uploads/2017/05/2017-05-30_18-00-33.png)
First up was Trent Middleton, a paralegal at the law firm representing Holmes, who explained documents illustrating Theranos' financial and operational history. Holmes' attorneys have pushed back in cross-examination, but on Friday they began to call witnesses of their own. Among numerous other witnesses, jurors also heard from a patient who received a false-positive HIV test from Theranos and a former lab director who shut down one of the company's labs after becoming concerned about data from another HIV test. This week they presented testimony alleging that Theranos doctored documents intended to show validation of the company's purportedly revolutionary blood-testing technology. Since September, federal prosecutors have attempted to make the case that Holmes misled patients and investors.